These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 30048283)

  • 1. Overview of Drugs Used to Treat Opioid Use Disorder.
    Aschenbrenner DS
    Am J Nurs; 2018 Aug; 118(8):25. PubMed ID: 30048283
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.
    Carney BL; Hadland SE; Bagley SM
    Pediatr Rev; 2018 Jan; 39(1):43-45. PubMed ID: 29292291
    [No Abstract]   [Full Text] [Related]  

  • 3. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-Based Treatment to Address Opioid Use Disorder.
    Leshner AI; Dzau VJ
    JAMA; 2019 Jun; 321(21):2071-2072. PubMed ID: 31046072
    [No Abstract]   [Full Text] [Related]  

  • 5. CE: Acute Pain Management for People with Opioid Use Disorder.
    Broglio K; Matzo M
    Am J Nurs; 2018 Oct; 118(10):30-38. PubMed ID: 30211703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder.
    Fipps DC; Oesterle TS; Kolla BP
    Semin Neurol; 2024 Aug; 44(4):441-451. PubMed ID: 38848746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of buprenorphine prescribing for the advanced practice psychiatric nurse.
    Kameg B; Fradkin D; Lepore M
    Perspect Psychiatr Care; 2022 Oct; 58(4):2059-2063. PubMed ID: 35092616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-Assisted Treatment for Opioid-Use Disorder.
    Oesterle TS; Thusius NJ; Rummans TA; Gold MS
    Mayo Clin Proc; 2019 Oct; 94(10):2072-2086. PubMed ID: 31543255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
    Herscher M; Fine M; Navalurkar R; Hirt L; Wang L
    Med Clin North Am; 2020 Jul; 104(4):695-708. PubMed ID: 32505261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions.
    Chang DC; Klimas J; Wood E; Fairbairn N
    Am J Drug Alcohol Abuse; 2018; 44(2):143-146. PubMed ID: 29190156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
    Harrison TK; Kornfeld H; Aggarwal AK; Lembke A
    Anesthesiol Clin; 2018 Sep; 36(3):345-359. PubMed ID: 30092933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone and buprenorphine treatments in patients with schizophrenia.
    Dervaux A; Plancke L; Amariei A; Trouiller P; Tahon M; Martinetti MP; Naassila M; Cottencin O; Danel T
    Schizophr Res; 2019 Jul; 209():286-288. PubMed ID: 31101511
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between dissociative symptoms and the medications used in the treatment of opioid use disorder.
    Gainer DM; Crawford TN; Fischer KB; Wright MD
    J Subst Abuse Treat; 2021 Feb; 121():108195. PubMed ID: 33357605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The science and practice of medication-assisted treatments for opioid dependence.
    Pecoraro A; Ma M; Woody GE
    Subst Use Misuse; 2012; 47(8-9):1026-40. PubMed ID: 22676570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics and current clinical practices of opioid treatment programs in the United States.
    Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
    Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.
    Camenga DR; Colon-Rivera HA; Muvvala SB
    J Stud Alcohol Drugs; 2019 Jul; 80(4):393-402. PubMed ID: 31495374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding and co-managing medication treatment options for opioid use disorder.
    Kay A; Shmuts R; Beck M
    Intern Emerg Med; 2022 Oct; 17(7):2159-2165. PubMed ID: 35138549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.